Literature DB >> 24030606

Metformin for antipsychotic-related weight gain and metabolic abnormalities: when, for whom, and for how long?

Christoph U Correll, Linmarie Sikich, Gloria Reeves, Mark Riddle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24030606     DOI： 10.1176/appi.ajp.2013.13060771

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  9 in total

1.  Outpatient metformin management of obese individuals with schizophrenia.

Authors:  Bertrand Winsberg; Ronald Wei; Natarajan Elangovan; Janet Camp-Lifshitz
Journal:  Prim Care Companion CNS Disord       Date:  2014-11-06

2.  Brief Report: Metformin for Antipsychotic-Induced Weight Gain in Youth with Autism Spectrum Disorder.

Authors:  Logan K Wink; Ryan Adams; Ernest V Pedapati; Kelli C Dominick; Emma Fox; Catherine Buck; Craig A Erickson
Journal:  J Autism Dev Disord       Date:  2017-07

3.  Metformin add-on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial.

Authors:  Christoph U Correll; Linmarie Sikich; Gloria Reeves; Jacqueline Johnson; Courtney Keeton; Marina Spanos; Sandeep Kapoor; Kristin Bussell; Leslie Miller; Tara Chandrasekhar; Eva M Sheridan; Sara Pirmohamed; Shauna P Reinblatt; Cheryl Alderman; Abigail Scheer; Irmgard Borner; Terrence C Bethea; Sarah Edwards; Robert M Hamer; Mark A Riddle
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

Review 4.  Pharmacological interventions for prevention of weight gain in people with schizophrenia.

Authors:  Sri Mahavir Agarwal; Nicolette Stogios; Zohra A Ahsan; Jonathan T Lockwood; Markus J Duncan; Hiroyoshi Takeuchi; Tony Cohn; Valerie H Taylor; Gary Remington; Guy E J Faulkner; Margaret Hahn
Journal:  Cochrane Database Syst Rev       Date:  2022-10-03

Review 5.  Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research.

Authors:  Jasmin Grigg; Roisin Worsley; Caroline Thew; Caroline Gurvich; Natalie Thomas; Jayashri Kulkarni
Journal:  Psychopharmacology (Berl)       Date:  2017-09-09       Impact factor: 4.530

Review 6.  Metabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management.

Authors:  Rebecca A Krill; Sanjiv Kumra
Journal:  Adolesc Health Med Ther       Date:  2014-09-26

Review 7.  Effect of adjunctive ranitidine for antipsychotic-induced weight gain: A systematic review of randomized placebo-controlled trials.

Authors:  Xiao-Jing Gu; Rui Chen; Chen-Hui Sun; Wei Zheng; Xin-Hu Yang; Shi-Bin Wang; Gabor S Ungvari; Chee H Ng; Andrei Golenkov; Grace K I Lok; Lu Li; Ines H I Chow; Fei Wang; Yu-Tao Xiang
Journal:  J Int Med Res       Date:  2017-07-18       Impact factor: 1.671

Review 8.  Bipolar Spectrum Disorders in Male Youth: The Interplay between Symptom Severity, Inflammation, Steroid Secretion, and Body Composition.

Authors:  Andreas Walther; Marlene Penz; Daniela Ijacic; Timothy R Rice
Journal:  Front Psychiatry       Date:  2017-10-18       Impact factor: 4.157

9.  Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled Trial of Metformin for Antipsychotic-Induced Weight Gain in Patients with First-Episode Psychosis: A Pilot Study.

Authors:  Charmaine Tang; Yi Chian Chua; Edimansyah Abdin; Mythily Subramaniam; Swapna Verma
Journal:  Int J Environ Res Public Health       Date:  2021-12-23       Impact factor: 3.390
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.